Search Results - "Bertini, Michele"
-
1
Current pharmacological treatments for COVID‐19: What's next?
Published in British journal of pharmacology (01-11-2020)“…Since December 2019 SARS‐Cov‐2 was found responsible for the disease COVID‐19, which has spread worldwide. No specific therapies/vaccines are yet available for…”
Get full text
Journal Article -
2
Safety of Anticancer Agents Used in Children: A Focus on Their Off-Label Use Through Data From the Spontaneous Reporting System
Published in Frontiers in pharmacology (07-05-2020)“…Among factors influencing the higher risk of developing unknown or rare adverse drug reactions (ADRs) among children and adolescents, there is the frequent…”
Get full text
Journal Article -
3
Did the New Italian Law on Mandatory Vaccines Affect Adverse Event Following Immunization's Reporting? A Pharmacovigilance Study in Southern Italy
Published in Frontiers in pharmacology (04-09-2018)“…Despite the well-recognized role of vaccines, coverage is far from optimal especially in children, representing a growing concern also in Italy. In order to…”
Get full text
Journal Article -
4
Adverse drug reactions during hepatitis C treatment with direct‐acting antivirals: The role of medication errors, their impact on treatment discontinuation and their preventability. New insights from the Campania Region (Italy) spontaneous reporting system
Published in Journal of clinical pharmacy and therapeutics (01-12-2018)“…Summary What is known and Objective Medication errors, such as unnecessary treatment discontinuation during treatment with direct‐acting antivirals (DAAs), can…”
Get full text
Journal Article -
5
Adverse drug reactions during hepatitis C treatment with direct-acting antivirals: The role of medication errors, their impact on treatment discontinuation and their preventability. New insights from the Campania Region (Italy) spontaneous reporting syste
Published in Journal of clinical pharmacy and therapeutics (01-12-2018)Get full text
Journal Article -
6
Assessment of clinical and radiological response tosorafenib in hepatocellular carcinoma patients
Published in 世界肝病学杂志:英文版(电子版) (2015)“…Sorafenib is an effective anti-angiogenic treatment forhepatocellular carcinoma (HCC). The assessment oftumor progression in patients treated with sorafenibis…”
Get full text
Journal Article -
7
Consenso sulla diagnostica di laboratorio per i pazienti in trattamento con farmaci anticoagulanti ad azione diretta. Sottoscritto dalla Società Italiana per lo Studio dell'Emostasi e della Trombosi (SISET), dalla Federazione Centri per la diagnosi della trombosi e la Sorveglianza delle terapie Antitrombotiche (FCSA), dalla Società Italiana di Biochimica Clinica e Biologia Molecolare Clinica (SIBioC) e dalla Società Italiana di Patologia Clinica e Medicina di Laboratorio (SIPMeL)
Published in La rivista italiana della medicina di laboratorio (01-05-2019)Get full text
Journal Article -
8
La ricerca del lupus anticoagulant: raccomandazioni del gruppo di studio sulla coagulazione di SIPMeL
Published in La rivista italiana della medicina di laboratorio (07-09-2018)“…Riassunto Per porre diagnosi di sindrome da anticorpi antifosfolipidi (APS) è necessario che siano presenti almeno un criterio clinico (trombosi…”
Get full text
Journal Article -
9
Linee guida SIPMeL per la ricerca dei polimorfismi nella diagnostica di screening della trombofilia
Published in La rivista italiana della medicina di laboratorio (01-06-2017)“…Riassunto Con il termine trombofilia si identifica una condizione clinica che determina un aumento del rischio di malattia tromboembolica venosa e di alcune…”
Get full text
Journal Article -
10
Clinical impact of selective transarterial chemoembolization on hepatocellular carcinoma: A cohort study
Published in World journal of gastroenterology : WJG (21-04-2009)“…AIM: To prospectively long term clinical impact evaluate the short and of selective transarterial chemoembolization (TACE) on fiver function in patients with…”
Get full text
Journal Article